M Beffinger, A Skwarska - Current pharmaceutical design, 2012 - ingentaconnect.com
… FLT3 inhibitors, targeting both FL and FLT3 kinase, might be more effective approach in AML
treatment. Here, we summarize up-to-date studies on FLT3 … to the conformational changes …